TABLE 7.
Variable | Group | Peak | Active vs. placebo between groups | ||
|
|
||||
N | Mean ± SD pg/ml | Mean diff ± SE pg/ml | p-value | ||
Th1/Th2 ratio | |||||
INFγ /IL4 | Active | 25 | 6.4 ± 1.6 | −2.1 ± 0.9 | 0.03 |
Placebo | 21 | 8.5 ± 4.4 | |||
TNFβ/IL4 | Active | 25 | 7.1 ± 2.2 | −2.0 ± 0.9 | 0.02 |
Placebo | 21 | 9.6 ± 4.5 | |||
TNFβ/IL3 | Active | 25 | 3.0 ± 1.2 | −11.4 ± 4.8 | 0.02 |
Placebo | 21 | 8.1 ± 13.5 |
N, number; SD, standard deviation; SE. standard error; ns, not significant; pg/ml, pictogram/ml; Th, T-helper cell; IL, interleukin; INF, interferon; TNF, tumor necrosis factor; GMSF, granulocyte colony-stimulating factor or macrophage colony-stimulating factor.